Femasys

FEMY · NASDAQ

$1.67+$0.04 (+2.45%)TodayMarket closed · Oct 20, 7:24 PM ET

Prev close $1.63

Latest news

Press releaseOct 20, 9:00 AM ETGlobe Newswire
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
Press releaseOct 14, 9:00 AM ETGlobe Newswire
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
Press releaseOct 8, 9:00 AM ETGlobe Newswire
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
Press releaseSep 15, 9:00 AM ETGlobe Newswire
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
Press releaseSep 9, 9:00 AM ETGlobe Newswire
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
Press releaseAug 26, 9:00 AM ETGlobe Newswire
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
NewsAug 19, 1:36 PM ETVandana Singh
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
NewsAug 19, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseAug 19, 9:00 AM ETGlobe Newswire
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
Press releaseAug 14, 4:05 PM ETGlobe Newswire
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Press releaseAug 12, 9:00 AM ETGlobe Newswire
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
NewsMay 22, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseMay 8, 4:05 PM ETGlobe Newswire
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
NewsDec 24, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsDec 22, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsDec 18, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseNov 25, 9:15 AM ETBusiness Wire
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
NewsNov 17, 7:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsNov 10, 7:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsNov 7, 4:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsOct 16, 1:08 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsOct 6, 9:01 AM ETAvi Kapoor
Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
NewsAug 26, 12:16 PM ETAvi Kapoor
Crude Oil Down 2%; US Durable Goods Orders Decline In July
NewsAug 26, 9:55 AM ETAvi Kapoor
US Stocks Mixed; American Woodmark Posts Downbeat Sales
NewsJun 11, 4:01 PM ET
The Analyst Verdict: Femasys In The Eyes Of 6 Experts
NewsMay 9, 8:00 AM ET
Analyst Expectations For Femasys's Future
NewsMar 18, 3:01 PM ET
Assessing Femasys: Insights From 4 Financial Analysts
NewsNov 27, 7:00 AM ET
The Latest Analyst Ratings For Femasys
NewsSep 12, 8:01 AM ET
Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs

Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control

Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care

Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio

Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations

Femasys Secures FDA Pathway for Non-Surgical Contraceptive

12 Health Care Stocks Moving In Wednesday's Intraday Session

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents

12 Health Care Stocks Moving In Friday's After-Market Session

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

Crude Oil Down 2%; US Durable Goods Orders Decline In July

US Stocks Mixed; American Woodmark Posts Downbeat Sales

The Analyst Verdict: Femasys In The Eyes Of 6 Experts

Analyst Expectations For Femasys's Future

Assessing Femasys: Insights From 4 Financial Analysts

The Latest Analyst Ratings For Femasys

Femasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)